Ritz E, Stefanski A, Rambausek M
Department of Internal Medicine, Ruperto Carola University, Heidelberg, Germany.
Am J Kidney Dis. 1995 Nov;26(5):808-13. doi: 10.1016/0272-6386(95)90448-4.
The genesis of hyperparathyroidism in uremia has turned out to be quite complex, involving low calcitriol, low ionized calcium, and possibly direct effects of high phosphate as well as the action of local factors and modifier genes determining the hyperplastic response of the gland. Growth is initially polyclonal and later monoclonal. In addition, the response of target tissues to parathyroid hormone (PTH) is attenuated ("PTH resistance"), and this may be due, at least in part, to diminished phenotypic expression of PTH receptors. In a series of elegant studies, it has been shown that PTH acts not only on the classical target organs of calcium homeostasis (ie, bone and kidney), but also on nonclassical. The role of PTH excess in the genesis of several features of the uremic syndrome, for example muscle dysfunction, cardiomyopathy, leukocyte and T-cell dysfunction or insulin secretion by pancreatic islet cells, has been established. These studies have borne out the prediction that PTH is a "uremic toxin."
尿毒症患者甲状旁腺功能亢进的发病机制已被证明相当复杂,涉及活性维生素D水平降低、离子钙水平降低,可能还有高磷的直接作用以及决定腺体增生反应的局部因素和修饰基因的作用。其生长最初是多克隆性的,后来是单克隆性的。此外,靶组织对甲状旁腺激素(PTH)的反应减弱(“PTH抵抗”),这可能至少部分归因于PTH受体的表型表达减少。在一系列精妙的研究中,已表明PTH不仅作用于钙稳态的经典靶器官(即骨骼和肾脏),还作用于非经典靶器官。PTH过量在尿毒症综合征若干特征(如肌肉功能障碍、心肌病、白细胞和T细胞功能障碍或胰岛细胞胰岛素分泌)发生过程中的作用已得到证实。这些研究证实了PTH是一种“尿毒症毒素”这一预测。